Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Non-Current Assets (2023 - 2025)

Xenetic Biosciences' Non-Current Assets history spans 6 years, with the latest figure at $313921.0 for Q4 2025.

  • For Q4 2025, Non-Current Assets changed 0.0% year-over-year to $313921.0; the TTM value through Dec 2025 reached $627842.0, down 81.36%, while the annual FY2025 figure was $313921.0, 0.0% changed from the prior year.
  • Non-Current Assets reached $313921.0 in Q4 2025 per XBIO's latest filing, roughly flat from $313921.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.0 million in Q4 2023 to a low of $313921.0 in Q4 2024.
  • Average Non-Current Assets over 3 years is $726846.4, with a median of $774431.0 recorded in 2023.
  • The largest YoY upside for Non-Current Assets was 44.56% in 2024 against a maximum downside of 69.17% in 2024.
  • A 3-year view of Non-Current Assets shows it stood at $1.0 million in 2023, then plummeted by 69.17% to $313921.0 in 2024, then changed by 0.0% to $313921.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Non-Current Assets are $313921.0 (Q4 2025), $313921.0 (Q1 2025), and $313921.0 (Q4 2024).